SENS Stock Analysis: Buy, Sell, or Hold?
SENS - Senseonics Holdings, Inc.
$5.28
-0.10 (-1.95%)
▼
5d:
-6.31%
30d:
-27.74%
90d:
-21.03%
HOLD
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When SENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SENS is currently trading at $5.28, which is considered oversold relative to its 30-day fair value range of $5.44 to $7.02.
Technical Outlook: Technically, SENS is in a downtrend. The price is currently testing key support at $6.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SENS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.80 (+156.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SENS is in a downtrend. The price is currently testing key support at $6.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SENS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.80 (+156.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.44 -
$7.02
Company Quality Score
55/100
(HOLD)
Options IV Signal
9th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 9th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 156.5% below Wall St target ($13.80)
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$5.44 -
$7.02
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.48
(9.2%)
Support & Resistance Levels
Support Level
$6.15
Resistance Level
$7.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.45
Wall Street Target
$13.80
(+156.5%)
Revenue Growth (YoY)
87.2%
Profit Margin
-214.2%
Share & Embed Analysis
Last updated: July 13, 2026 11:16 AM ET
Data refreshes hourly during market hours. Next update: 12:16 PM
Data refreshes hourly during market hours. Next update: 12:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SENS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Douglas A Roeder
BUY
17500 shares
2026-03-13
Timothy T Goodnow
BUY
17225 shares
2026-03-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
